|
1
|
Lu B, Zhou Y, Su Z, Yan A and Ding P:
Effect of CCL2 siRNA on proliferation and apoptosis in the U251
human glioma cell line. Mol Med Rep. 16:3387–3394. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Latha K, Yan J, Yang Y, Gressot LV, Kong
L, Manyam G, Ezhilarasan R, Wang Q, Sulman EP, Xu J, et al:
Abstract 5606: Fibrinogen-like protein 2 drives malignant tumor
progression in glioma. Cancer Res. 77:56062017.
|
|
3
|
Ellert-Miklaszewska A, Ciechomska IA and
Kaminska B: Chapter e11 cannabinoid signaling in glioma cells and
therapeutic implications. Handbook Cannabis Relat Pathologies.
e111–e121. 2017. View Article : Google Scholar
|
|
4
|
Lv QL, Du H, Liu YL, Huang YT, Wang GH,
Zhang X, Chen SH and Zhou HH: Low expression of microRNA-320b
correlates with tumorigenesis and unfavorable prognosis in glioma.
Oncol Rep. 38:959–966. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kalogianni DP, Kalligosfyri PM, Kyriakou
IK and Christopoulos TK: Advances in microRNA analysis. Anal
Bioanal Chem. 410:695–713. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Santangelo A, Imbrucè P, Gardenghi B,
Belli L, Agushi R, Tamanini A, Munari S, Bossi AM, Scambi I, Benati
D, et al: A microRNA signature from serum exosomes of patients with
glioma as complementary diagnostic biomarker. J Neurooncol.
136:51–62. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang J, Lv J, Zhang F, Che H, Liao Q,
Huang W, Li S and Li Y: MicroRNA-211 expression is down-regulated
and associated with poor prognosis in human glioma. J Neurooncol.
133:553–559. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Li Y, Ge P and Ma C: MiR-126
Regulates the ERK pathway via targeting KRAS to inhibit the glioma
cell proliferation and invasion. Mol Neurobiol. 54:137–145. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cui BH and Hong X: miR-6852 serves as a
prognostic biomarker in colorectal cancer and inhibits tumor growth
and metastasis by targeting TCF7. Exp Ther Med. 16:879–885.
2018.PubMed/NCBI
|
|
10
|
Yu H, Zhang J, Wen Q, Dai Y, Zhang W, Li F
and Li J: MicroRNA-6852 suppresses cell proliferation and invasion
via targeting forkhead box J1 in gastric cancer. Exp Ther Med.
16:3249–3255. 2018.PubMed/NCBI
|
|
11
|
Poudyal D, Herman A, Adelsberger JW, Yang
J, Hu X, Chen Q, Bosche M, Sherman BT and Imamichi T: A novel
microRNA, hsa-miR-6852 differentially regulated by Interleukin-27
induces necrosis in cervical cancer cells by downregulating the
FoxM1 expression. Sci Rep. 8:9002018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin L, Cai J and Jiang C: Recent advances
in targeted therapy for glioma. Curr Med Chem. 24:1365–1381. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin C, Li M, Ouyang Y, Tan Z and Jiang Y:
MiR-424 functions as a tumor suppressor in glioma cells and is
down-regulated by DNA methylation. J Neurooncol. 133:247–255. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xiao ZQ, Yin TK, Li YX, Zhang JH and Gu
JJ: miR-130b regulates the proliferation, invasion and apoptosis of
glioma cells via targeting of CYLD. Oncol Rep. 38:167–174. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo X, Zhang R, Liu J, Li M, Song C, Dovat
S, Li J and Ge Z: Characterization of LEF1 high expression and
novel mutations in adult acute lymphoblastic leukemia. PLoS One.
10:e01254292015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Menter T, Trivedi P, Ahmad R, Flora R,
Dirnhofer S, Tzankov A and Naresh KN: Diagnostic utility of
lymphoid enhancer binding factor 1 immunohistochemistry in small
B-cell lymphomas. Am J Clin Pathol. 147:292–300. 2017.PubMed/NCBI
|
|
18
|
Santiago L, Daniels G, Wang D, Deng FM and
Lee P: Wnt signaling pathway protein LEF1 in cancer, as a biomarker
for prognosis and a target for treatment. Am J Cancer Res.
7:1389–1406. 2017.PubMed/NCBI
|
|
19
|
Fang S, Lei LI, Liu M, Tsang J and Guan X:
Abstract 2434: LEF1 negatively regulates differentiation of HCC by
activation of Notch signaling pathway. Cancer Res. 77:24342017.
|
|
20
|
Wang WJ, Yao Y, Jiang LL, Hu TH, Ma JQ,
Ruan ZP, Tian T, Guo H, Wang SH and Nan KJ: Increased LEF1
expression and decreased Notch2 expression are strong predictors of
poor outcomes in colorectal cancer patients. Dis Markers.
35:395–405. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao X, Mi Y, Ma Y and Jin W: LEF1
regulates glioblastoma cell proliferation, migration, invasion, and
cancer stem-like cell self-renewal. Tumor Biol. 35:11505–11511.
2014. View Article : Google Scholar
|
|
22
|
Pećina-Šlaus N, Kafka A, Tomas D, Marković
L, Okštajner PK, Sukser V and Krušlin B: Wnt signaling
transcription factors TCF-1 and LEF-1 are upregulated in malignant
astrocytic brain tumors. Histol Histopathol. 29:1557–1564.
2014.PubMed/NCBI
|
|
23
|
Liang J, Li X, Li Y, Wei J, Daniels G,
Zhong X, Wang J, Sfanos K, Melamed J, Zhao J and Lee P: LEF1
targeting EMT in prostate cancer invasion is mediated by miR-181a.
Am J Cancer Res. 5:1124–1132. 2015.PubMed/NCBI
|
|
24
|
Lyou Y, Habowski AN, Chen GT and Waterman
ML: Inhibition of nuclear Wnt signaling: Challenges of an elusive
target for cancer therapy. Br J Pharmacol. 174:4589–4599. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qiu J, Hao Y, Huang S, Ma Y, Li X, Li D
and Mao Y: MiR-557 works as a tumor suppressor in human lung
cancers by negatively regulating LEF1 expression. Tumour Biol.
39:10104283177094672017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu Y, Yan W, Zhang W, Chen L, You G, Bao
Z, Wang Y, Wang H, Kang C and Jiang T: MiR-218 reverses high
invasiveness of glioblastoma cells by targeting the oncogenic
transcription factor LEF1. Oncol Rep. 28:1013–1021. 2012.
View Article : Google Scholar : PubMed/NCBI
|
